Inventor · disambiguated record
Qingping Zeng
Also filed as: ZENG QINGPING
28 granted patents·9 pending applications·347 citations·filing 1993–2021
97Inventor score
Top patents by PatentIndex Score
37 records- 0195US7919514B2Thiadiazole compounds and methods of useAMGEN INC·Filed 2008·Granted Apr 5, 2011·42 cites·9 claims
- 0294US7897619B2Heterocyclic modulators of PKBAMGEN INC·Filed 2008·Granted Mar 1, 2011·42 cites·41 claims
- 0394US7700636B2Thiadiazole compounds and methods of useAMGEN INC·Filed 2008·Granted Apr 20, 2010·33 cites·11 claims
- 0494US7514566B2Thiazole compounds and methods of useAMGEN INC·Filed 2007·Granted Apr 7, 2009·38 cites·48 claims
- 0594US7354944B2Thiadiazole compounds and methods of useAMGEN INC·Filed 2005·Granted Apr 8, 2008·38 cites·8 claims
- 0693US7919504B2Thiadiazole modulators of PKBAMGEN INC·Filed 2008·Granted Apr 5, 2011·30 cites·16 claims
- 0790US9493454B2Multiple kinase pathway inhibitorsMANNKIND CORP·Filed 2013·Granted Nov 15, 2016·13 cites·24 claims
- 0890US7858666B2IRE-1α inhibitorsMANNKIND CORP·Filed 2008·Granted Dec 28, 2010·13 cites·24 claims
- 0989USD999411SLED solar string lightSHENZHEN YOUCHENG SUPPLY CHAIN TECH CO LTD·Filed 2021·Granted Sep 19, 2023·7 cites·1 claims
- 1088US9714247B2Multiple kinase pathway inhibitorsMANNKIND CORP·Filed 2016·Granted Jul 25, 2017·6 cites·10 claims
- 1186US6867217B1Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Mar 15, 2005·14 cites·20 claims
- 1284US9693992B2IRE-1α inhibitorsMANNKIND CORP·Filed 2015·Granted Jul 4, 2017·4 cites·10 claims
- 1384US8614253B2IRE-1α inhibitorsPATTERSON JOHN BRUCE·Filed 2010·Granted Dec 24, 2013·7 cites·56 claims
- 1482US9040714B2IRE-1α inhibitorsZENG QINGPING·Filed 2011·Granted May 26, 2015·6 cites·2 claims
- 1579US6664255B1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2000·Granted Dec 16, 2003·7 cites·27 claims
- 1678US9867803B2IRE-1α inhibitorsSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2017·Granted Jan 16, 2018·2 cites·28 claims
- 1774US10357475B2IRE-1α inhibitorsFOSUN ORINOVE PHARMATECH INC·Filed 2017·Granted Jul 23, 2019·1 cites·13 claims
- 1874US9241942B2IRE-1α inhibitorsMANNKIND CORP·Filed 2013·Granted Jan 26, 2016·1 cites·57 claims
- 1974US6528517B1Synthesis of quinobenzoxazine analogues with topoisomerase II and quadruplex interactions for use as antineoplastic agentsUNIV TEXAS·Filed 1999·Granted Mar 4, 2003·21 cites·20 claims
- 2072US11337956B2IRE-1α inhibitorsFOSUN ORINOVE PHARMATECH INC·Filed 2019·Granted May 24, 2022·0 cites·9 claims
- 2171US8084479B2Thiazole compounds and methods of useZENG QINGPING·Filed 2009·Granted Dec 27, 2011·1 cites·20 claims
- 2268US9493435B2IRE-1α inhibitorsZENG QINGPING·Filed 2010·Granted Nov 15, 2016·1 cites·17 claims
- 2365US6908919B2Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Granted Jun 21, 2005·3 cites·27 claims
- 2464US5493012AIon triggered alkylation of biological targets by silyloxy aromatic agentsUNIV NEW YORK STATE RES FOUND·Filed 1993·Granted Feb 20, 1996·9 cites·50 claims
- 2560US9981901B2IRE-1α inhibitorsFOSUN ORINOVE PHARMATECH INC·Filed 2016·Granted May 29, 2018·0 cites·2 claims
- 2655US2005165062A1Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2754US2018072745A1IRE-1alpha INHIBITORSSHANGHAI FOSUN PHARMACEUTICAL NDUSTRIAL DEV CO LTD·Filed 2017·Application pending·0 cites
- 2852US5831073AIon triggered alkylation of biological targets by silyloxy aromatic agentsUNIV NEW YORK STATE RES FOUND·Filed 1996·Granted Nov 3, 1998·8 cites·30 claims
- 2951US9856266B2IRE-1alpha inhibitorsSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2016·Granted Jan 2, 2018·0 cites·17 claims
- 3048US2005043313A1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3148US2004102448A1Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3246US2023067666A1Method for preparing coumarin compounds substituted by amidoalkyl at 3-position, the products and related intermediates thereofFOSUN ORINOVE PHARMATECH INC·Filed 2020·Application pending·0 cites
- 3343US2021260069A1IRE1a INHIBITOR IN COMBINATION WITH CANCER THERAPEUTIC AGENT FOR CANCER TREATMENTFOSUN ORINOVE PHARMATECH INC·Filed 2019·Application pending·0 cites
- 3440US2004082585A1Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Application pending·0 cites
- 3537US2004106626A16-Membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascadePHARMACIA CORP·Filed 2002·Application pending·0 cites
- 3637US2011263647A1Fluoroisoquinoline substituted thiazole compounds and methods of useAMGEN INC·Filed 2010·Application pending·0 cites
- 3736US7119094B1Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascadeWARNER LAMBERT CO·Filed 2000·Granted Oct 10, 2006·0 cites·46 claims
Join the waitlist — get patent alerts
Get an alert when Qingping Zeng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →